Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2907
Peer-review started: September 7, 2023
First decision: September 20, 2023
Revised: September 30, 2023
Accepted: November 14, 2023
Article in press: November 14, 2023
Published online: December 27, 2023
Processing time: 111 Days and 9.6 Hours
Colorectal cancer (CRC) is a prevalent malignant tumor involving adenomas that develop into malignant lesions. CRC can be detected through early screening and treated with surgery or colonoscopy, increasing the survival rate by 90%. Therefore, carcinoembryonic antigen (CEA) testing has been suggested for CRC diagnosis, particularly for detecting disease recurrence and monitoring the response to therapy. However, the use of CEA in the screening of CRC in asymptomatic individuals remains controversial and, therefore, is not recommended in routine practice. Controversy surrounds CEA use in practice owing to variability in the measurement of CEA levels.
Controversy surrounds CEA use in practice owing to variability in the measurement of CEA levels. Foremost, enzyme-linked immunosorbent assays, which are often used to test for the presence of CEA, can vary depending on the testing procedures, yielding inconsistent CEA levels.
However, considering the inconsistencies in using CEA for CRC detection, this study aimed to evaluate current evidence regarding the diagnostic power of CEA levels in the early detection of CRC recurrence in adults.
Our research methods were a systematic review and meta-analysis significance of CEA detection in the early diagnosis of CRC.
CEA testing is often used with other diagnostic tests, such as colonoscopy or biopsy, for early CRC diagnosis. This is important as early diagnosis can optimize treatment and, thus, patient outcomes and survival. Therefore, the monitoring of CEA levels should be considered as one component of a comprehensive postoperative follow-up for early diagnosis of CRC recurrence.
We concluded that the CEA detection was significant in the early diagnosis of CRC.
Our research perspectives involved investigating the sensitivity and specificity of CEA as a diagnostic marker for CRC. Also, we sought to examine the possibility of early detection of CRC and how it improves the possibility of early treatment.